Search Results - "Weinreb, J"
-
1
Spinal cord injury models: a review
Published in Spinal cord (01-08-2014)“…Background: Animal spinal cord injury (SCI) models have proved invaluable in better understanding the mechanisms involved in traumatic SCI and evaluating the…”
Get full text
Journal Article -
2
Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: A study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry
Published in Journal of bone and mineral research (01-08-2012)“…We hypothesized that overall disease activity or the severity of involvement of individual disease compartments, as measured by clinical and surrogate markers,…”
Get full text
Journal Article -
3
Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS)
Published in Orphanet journal of rare diseases (01-04-2022)“…Limited real-world data from routine clinical care are available on the safety and effectiveness of treatment with taliglucerase alfa in patients with Gaucher…”
Get full text
Journal Article -
4
Gaucher disease and cancer incidence: a study from the Gaucher Registry
Published in Blood (15-06-2005)“…Patients with Gaucher disease (GD) are alleged to be at an increased risk of malignant disorders, possibly due to potential chronic stimulation of the immune…”
Get full text
Journal Article -
5
End-Organ Function and Exercise Performance in Patients With Fontan Circulation: What Characterizes the High Performers?
Published in Journal of the American Heart Association (15-12-2020)“…Background The physiologic hallmarks of the Fontan circulation-chronically elevated central venous pressures and low cardiac output-have significant effects…”
Get full text
Journal Article -
6
Therapeutic goals in the treatment of Gaucher disease
Published in Seminars in hematology (01-10-2004)“…Gaucher disease, the most common lysosomal storage disorder, is a heterogeneous multisystem condition. Patients with non-neuronopathic (type 1) Gaucher disease…”
Get full text
Journal Article -
7
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry
Published in The American journal of medicine (01-08-2002)“…Gaucher disease is the first lysosomal storage disorder to be treated with macrophage-targeted enzyme replacement therapy. Previous studies in relatively small…”
Get more information
Journal Article -
8
The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease
Published in Clinical genetics (01-03-2007)“…The effect of enzyme replacement therapy (ERT) on bone crisis and bone pain was investigated in patients with Gaucher disease (GD) type 1 followed over 4…”
Get full text
Journal Article -
9
The attenuated/late onset lysosomal storage disorders: Therapeutic goals and indications for enzyme replacement treatment in Gaucher and Fabry disease
Published in Baillière's best practice & research. Clinical endocrinology & metabolism (01-03-2015)“…Enzyme replacement therapies have been developed and authorized for commercial use for six different lysosomal storage disorders. For Gaucher disease, Fabry…”
Get full text
Journal Article -
10
Patients with Gaucher disease display systemic oxidative stress dependent on therapy status
Published in Molecular genetics and metabolism reports (01-12-2020)“…Gaucher disease is an autosomal recessive metabolic disorder caused by mutations in GBA1, which encodes for the lysosomal hydrolase enzyme,…”
Get full text
Journal Article -
11
The international cooperative Gaucher group (ICCG) Gaucher registry
Published in Best practice & research. Clinical haematology (01-12-2023)“…Gaucher disease GD), is a rare lysosomal storage disorder caused by deficient acid β-glucosylceramidase activity and accumulation of glucosylceramide in tissue…”
Get full text
Journal Article -
12
Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study
Published in Clinical genetics (01-05-2008)“…Progressive skeletal disease accounts for some of the most debilitating complications of type 1 Gaucher disease. In this 48‐month, prospective, non‐randomized,…”
Get full text
Journal Article -
13
Abdominal MR imaging with a volumetric interpolated breath-hold examination
Published in Radiology (01-09-1999)“…To compare a T1-weighted, three-dimensional (3D), gradient-echo (GRE) sequence for magnetic resonance (MR) imaging of the body (volumetric interpolated…”
Get more information
Journal Article -
14
Skeletal aspects of Gaucher disease: a review
Published in British journal of radiology (01-01-2002)“…In Gaucher disease, a genetic deficiency in the activity of the lysosomal enzyme beta-glucocerebrosidase (acid beta-glucosidase) causes monocytes and…”
Get full text
Conference Proceeding Journal Article -
15
Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation
Published in Radiology (01-05-2001)“…To determine the sensitivity and specificity of magnetic resonance (MR) imaging for detection of hepatocellular carcinoma (HCC) and dysplastic nodules (DNs) by…”
Get more information
Journal Article -
16
Presenting signs and patient co‐variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED‐C) Delphi initiative
Published in Internal medicine journal (01-05-2019)“…Background Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease…”
Get full text
Journal Article -
17
Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector
Published in Radiology (01-12-1996)“…To determine the usefulness of a timing examination performed with 1 mL gadopentetate dimeglumine administered with a magnetic resonance (MR) power injector at…”
Get more information
Journal Article -
18
Reduction of Plasma Globotriaosylsphingosine Levels After Switching from Agalsidase Alfa to Agalsidase Beta as Enzyme Replacement Therapy for Fabry Disease
Published in JIMD Reports, Volume 25 (01-01-2016)“…Introduction: Agalsidase alfa and agalsidase beta, recombinant enzyme preparations for treatment of Fabry disease (FD), have different approved dosing…”
Get full text
Book Chapter Journal Article -
19
A validated disease severity scoring system for adults with type 1 Gaucher disease
Published in Genetics in medicine (01-01-2010)“…A validated disease severity scoring system (DS3) for Gaucher disease type 1 (GD1) is needed to standardize patient monitoring and to define patient cohorts in…”
Get full text
Journal Article -
20
MR imaging of the breast
Published in Radiology (01-09-1995)“…Studies suggest that magnetic resonance (MR) imaging may have a variety of roles in the detection and management of breast disease. However, because study…”
Get more information
Journal Article